Design
Preclinical
Authors
Loading...
Hypothesis-generating for H19/PTBP1/SREBP1 in fatty liver; leaves open human validation before any clinical relevance.
The study identifies a novel H19/PTBP1/SREBP1 signaling pathway involved in the pathogenesis of fatty liver.
Liu et al. (2017) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: